Nematoda infectious disease
disease diseaseOn this page
Also known as Disease due to NematodaInfection, NematodeInfections, NematodeNematoda caused disease or disorderNematoda disease or disorderNematode InfectionNematode InfectionsNematodiasis
Summary
Nematoda infectious disease (MONDO:0005871) is a disease and 2 clinical trials. Top therapeutic interventions include albendazole. A subtype of helminthiasis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 2
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Nematoda infectious disease |
| Mondo ID | MONDO:0005871 |
| EFO | EFO:0007391 |
| MeSH | D009349 |
| SNOMED CT | 84706005 |
| UMLS | C0027583 |
| MedGen | 45025 |
| Is cancer (heuristic) | no |
Also known as: Disease due to Nematoda · disease due to nematoda · Infection, Nematode · Infections, Nematode · Nematoda caused disease or disorder · Nematoda disease or disorder · Nematode Infection · Nematode infection · Nematode Infections · Nematodiasis
Disease family
This is a subtype of helminthiasis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › parasitic infectious disease › helminthiasis › Nematoda infectious disease
Related subtypes (21): acanthocephaliasis, heterophyiasis, metagonimiasis, fascioliasis, fasciolopsiasis, monieziasis, clonorchiasis, dicrocoeliasis, echinostomiasis, fascioloidiasis, gnathomiasis, hymenolepiasis, necatoriasis, opisthorchiasis, paragonimiasis, trichostrongyloidiasis, schistosomiasis, filariasis, angiostrongyliasis, intestinal helminthiasis, Cestode infectious disease
Subtypes (2): Enoplea infectious disease, Rhabditida infectious disease
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 2.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE4 | 1 |
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02397772 | PHASE4 | COMPLETED | Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya |
| NCT00001245 | Not specified | COMPLETED | Study of Patients With Strongyloides Stercoralis Infection |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| ALBENDAZOLE | 4 | 1 |
Related Atlas pages
- Drugs: Albendazole